A small cohort study found that a wearable hand sensor that uses artificial intelligence reduced subconscious nighttime ...
In this Q&A, Marty Becker, DVM, Elite FFCP-V and Paul Bloom, DVM, DACVD, DABVP (Canine and Feline), Elite FFCP-III share ...
Boulder-based Enveda Biosciences, which uses machine learning to discover naturally occurring drug compounds, plans to begin testing ENV-294, its leading drug candidate developed to treat atopic ...
AD, The most common inflammatory skin disorder worldwide, is a highly heterogeneous condition with current treatments that do ...
Data from a retrospective multicenter study, along with a review of previous trials, supported the real-world utility of ...
Tapinarof, however, offers a potential solution by improving the skin barrier, reducing inflammation and relieving itch ...
Experiencing stressful life events in childhood was associated with an increased risk for active and severe atopic dermatitis ...
The celebrity dermatologist talks about finding her moment of clarity in finding relief for her eczema symptoms and how she ...
Read on to learn more about the types and symptoms of dermatitis. This article also looks at causes, treatment options, and more. Atopic dermatitis, or eczema, can run in families, and usually ...
Apogee begins patient dosing in Part B of phase 2 APEX trial of APG777 to treat moderate-to-severe atopic dermatitis: San Francisco Tuesday, February 4, 2025, 18:00 Hrs [IST] Apog ...
FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results